HAP Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

HAP Trading’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-45,000	Closed	-$68K	–	1566
2019 Q2	$68K	Sell	45,000 -16,500	-27%	-$1.78M	0.01%	677
2019 Q1	$3K	Buy	61,500 +14,900	+32%	+$1.1M	﹤0.01%	1048
2018 Q4	$362K	Buy	46,600 +24,200	+108%	+$1.05M	0.02%	422
2018 Q3	$147K	Buy	22,400 +9,300	+71%	+$636K	0.01%	492
2018 Q2	$47K	Sell	13,100 -12,600	-49%	-$972K	﹤0.01%	689
2018 Q1	$75K	Sell	25,700 -32,800	-56%	-$1.89M	﹤0.01%	590
2017 Q4	$562K	Buy	+58,500	New	+$4.2M	0.02%	373
2015 Q4	–	Sell	-17,700	Closed	-$384K	–	1199
2015 Q3	$384K	Buy	17,700 +7,600	+75%	+$397K	0.02%	418
2015 Q2	$146K	Buy	+10,100	New	+$668K	0.01%	522

HAP Trading's ONCE Position: Q4 2019 in Review

HAP Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 21,739 shares — an estimated $2.11M sold.

HAP Trading first reported a position in ONCE in Q4 2017 and held it in 3 quarters. The position peaked at $3.43M in Q4 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

HAP Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
HAP Trading sold 21,739 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.11M.
HAP Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
HAP Trading's Spark Therapeutics, Inc. Common Stock position peaked at $3.43M in Q4 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.